This is especially true for patients with autoimmune PAP, where there is a highly sensitive and specific simple serum test available for GM-CSF autoantibodies that can reduce the cost and morbidity associated with more invasive testing such as lung biopsies and is critical in making a definitive diagnosis of autoimmune PAP. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.